Trial Profile
Phase 3 study of dupilumab in the patients with bullous pemphigoid
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2020
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Bullous pemphigoid
- Focus Therapeutic Use
- 06 Feb 2020 Status changed from planning to recruiting, according to a Sanofi media release.
- 15 Nov 2019 New trial record